Sorrento Therapeutics, Inc. (SRNE)
0.0003
0.00 (0.00%)
USD |
OTCM |
Sep 18, 16:00
Sorrento Therapeutics Total Return Level : 0.0003 for Sept. 18, 2026
Total Return Level Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Return Level Data
| Date | Value |
|---|---|
| September 18, 2026 | 0.0003 |
| September 17, 2026 | 0.0004 |
| September 16, 2026 | 0.0004 |
| September 15, 2026 | 0.0004 |
| September 14, 2026 | 0.0004 |
| September 11, 2026 | 0.0004 |
| September 10, 2026 | 0.0004 |
| September 09, 2026 | 0.0005 |
| September 08, 2026 | 0.0004 |
| September 04, 2026 | 0.0006 |
| September 03, 2026 | 0.0006 |
| September 02, 2026 | 0.0006 |
| September 01, 2026 | 0.0006 |
| August 31, 2026 | 0.0005 |
| August 28, 2026 | 0.0005 |
| August 27, 2026 | 0.0005 |
| August 26, 2026 | 0.0009 |
| August 25, 2026 | 0.0007 |
| August 24, 2026 | 0.0008 |
| August 21, 2026 | 0.0008 |
| August 20, 2026 | 0.0008 |
| August 19, 2026 | 0.0008 |
| August 18, 2026 | 0.0008 |
| August 17, 2026 | 0.0007 |
| August 14, 2026 | 0.0007 |
| Date | Value |
|---|---|
| August 13, 2026 | 0.0007 |
| August 12, 2026 | 0.0005 |
| August 11, 2026 | 0.0004 |
| August 10, 2026 | 0.0004 |
| August 07, 2026 | 0.0005 |
| August 06, 2026 | 0.0005 |
| August 05, 2026 | 0.0006 |
| August 04, 2026 | 0.0006 |
| August 03, 2026 | 0.0005 |
| July 31, 2026 | 0.0005 |
| July 30, 2026 | 0.0005 |
| July 29, 2026 | 0.0005 |
| July 28, 2026 | 0.0005 |
| July 27, 2026 | 0.0004 |
| July 24, 2026 | 0.0004 |
| July 23, 2026 | 0.001 |
| July 22, 2026 | 0.001 |
| July 21, 2026 | 0.001 |
| July 20, 2026 | 0.001 |
| July 17, 2026 | 0.001 |
| July 16, 2026 | 0.001 |
| July 15, 2026 | 0.0006 |
| July 14, 2026 | 0.0006 |
| July 13, 2026 | 0.0007 |
| July 10, 2026 | 0.0007 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Return Level Benchmarks
| ACADIA Pharmaceuticals, Inc. | 27.29 |
| Alnylam Pharmaceuticals, Inc. | 239.56 |
| Anika Therapeutics, Inc. | 20.81 |
| Savara, Inc. | 5.37 |
| Vericel Corp. | 40.02 |